Delos Capital funds innovation in therapeutics and medtech. The fund focuses on clinical and pre- clinical stage companies.
DELOS CAPITAL invests in companies whose products or development programs have demonstrated the promising potentials for saving lives and enhancing the quality of patients’ life.
Delos Capital seeks to fund the development and commercialization of novel treatments with the potential of improving the lives of patients, reduce costs and increase quality of care. Delos Capital is investing in the most innovative biopharmaceutical solutions to meet the needs of patients around the globe.
Delos Capital invests in companies developing devices that address unmet medical and clinical needs in the areas of interventional cardiology, neurology & ophthalmology etc.